IONIS PHARMACEUT reported $142K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Arrowhead Research ARWR:US USD 198K 0
Astellas Pharma 4503:JP JPY 103B 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Esperion Therapeutics ESPR:US USD 72K 7K
Exelixis EXEL:US USD 323K 1000
Halozyme Therapeutics HALO:US USD 135K 3K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 890M 0
Omeros OMER:US USD 627K 0
Ptc Therapeutics PTCT:US USD 71K 0
Roche Holding ROG:VX 107M 53M
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0